ClinicalTrials.Veeva

Menu

Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor Necrosis Factor-alpha Levels in Children

A

Aydin Adnan Menderes University

Status

Completed

Conditions

Early Childhood Caries

Treatments

Diagnostic Test: ELISA

Study type

Observational

Funder types

Other

Identifiers

NCT04958005
2020/190

Details and patient eligibility

About

This study aimed to evaluate the levels of interleukin 10, interleukin 6, interleukin 32 and tumor necrosis factor-alpha (TNF-α) in saliva of children with early childhood caries.

Full description

Fifty six children ( 28 with early childhood caries and 28 without early childhood caries ; age range 3-6 years) will be recruited for the study. Probing pocket depth (PPD), gingival index (GI) and plaque index (PI) will be recorded and saliva samples will be collected. Interleukin-32, Interleukin-10, Interleukin-6 and TNF-α will be analyzed in saliva samples by ELISA.

Enrollment

58 patients

Sex

All

Ages

3 years to 70 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children with untreated early chilhood caries
  • Age between 3 and 6 years

Exclusion criteria

  • Having a systemic problem or mental retardation
  • Children with treated caries

Trial design

58 participants in 2 patient groups

Children with early chilhood caries
Description:
Early chilhood caries group
Treatment:
Diagnostic Test: ELISA
Without early chilhood caries
Description:
Control group
Treatment:
Diagnostic Test: ELISA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems